| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/14/2010 | US20100008989 Process for manufacture of gelatin solutions and products thereof |
| 01/14/2010 | US20100008972 Film for active ingredients dermal and transdermal administration |
| 01/14/2010 | US20100008913 Methods and compositions for treating platelet-related disorders |
| 01/14/2010 | US20100008888 Co-administration of cg250 and il-2 or ifn-alpha for treating cancer such as renal cell carcinomas |
| 01/14/2010 | CA2743975A1 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 01/14/2010 | CA2730154A1 The application of potassium 2-(1-hydroxypentyl)-benzoate (d1-phpb) for the prevention and treatment of alzheimer's disease |
| 01/14/2010 | CA2730079A1 Processes for the preparation of crystalline forms of sunitinib malate |
| 01/14/2010 | CA2725039A1 Nutritional composition containing oligosaccharide mixture |
| 01/13/2010 | EP2143726A1 Nucleic acid comprising zwitterionic nucleotides |
| 01/13/2010 | EP2143716A1 Pyrazine derivatives, methods of use, and methods for preparing same |
| 01/13/2010 | EP2143714A1 Tetrahydroisoquinoline compound |
| 01/13/2010 | EP2143713A1 Novel pyrrolinone derivative and medicinal composition containing the same |
| 01/13/2010 | EP2143443A1 Combined use of dipeptidyl peptidase iv inhibitor compound and sweetener |
| 01/13/2010 | EP2143439A1 Protective agent for transplanted organ |
| 01/13/2010 | EP2143438A1 Compositions and methods for the diagnosis and treatment of tumor |
| 01/13/2010 | EP2143437A1 Compositions and methods for the diagnosis and treatment of tumor |
| 01/13/2010 | EP2143434A1 Composition for promoting ketone compound formation |
| 01/13/2010 | EP2143424A1 Oral pharmaceutical preparation for colon-specific delivery |
| 01/13/2010 | EP2143420A1 Formulation comprising mutant/s of lysosomal alpha-galactosidase A for the treatment of Fabry disease |
| 01/13/2010 | EP2143341A1 Nutritional Composition Containing Oligosaccharide Mixture |
| 01/13/2010 | EP2142197A2 Method for the treatment of fabry disease using pharmacological chaperones |
| 01/13/2010 | EP2142184A1 Use of s1p receptor modulator |
| 01/13/2010 | EP1499886B1 Methods and compositions for inducing an immune response |
| 01/13/2010 | EP1465886B1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/13/2010 | EP1422229B1 Porphyrin-metal complexes and oxygen infusions containing the same |
| 01/13/2010 | EP1211242B1 Prostaglandin derivatives |
| 01/13/2010 | EP1144388B1 Acyl derivatives which treat vla-4 related disorders |
| 01/13/2010 | CN101624372A Lactam compound |
| 01/13/2010 | CN100579974C Podocarpus extract and its preparation method |
| 01/13/2010 | CN100579534C Application of S-adenyhomotype cysteine in medical preparation |
| 01/13/2010 | CN100579518C Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 01/13/2010 | CN100579393C Poria-cocos eight-treasures noodles and preparing method |
| 01/13/2010 | CN100579382C Health-care tea containing umbilicaria |
| 01/13/2010 | CN100579381C Health-care tea containing nepherite |
| 01/13/2010 | CN100579379C Ageratum tea |
| 01/12/2010 | US7645797 Gamma aminobutyric acid antagonist such as naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative diseases; analgesics; drug withdrawal |
| 01/12/2010 | US7645796 Amino acid composition promoting collagen synthesis |
| 01/12/2010 | US7645770 Phenylalanine enamide derivatives |
| 01/12/2010 | US7645761 Indoline derivatives |
| 01/12/2010 | US7645758 (4-Methyl-piperazin-1-yl)-(6H-thieno[2,3-b]pyrrol-5-yl)-methanone; (2,3-Dichloro-6H-thieno[2,3-b]pyrrol-5-yl)-(4-methyl-piperazin-1-yl)-methanone; histamine H4 receptor antagonist; treats allergic rhinitis |
| 01/12/2010 | US7645754 Pyrrolopyrimidine A2B selective antagonist compounds, their synthesis and use |
| 01/12/2010 | US7645601 Isolated PGE synthase, provided from encoding nucleic acid. Methods of production and use. Assays for modulators, especially inhibitors, of PGE synthase activity. |
| 01/12/2010 | CA2483678C 6-11 bicyclic ketolide derivatives |
| 01/12/2010 | CA2481461C Derivatives of n-[phenyl(piperidin-2-yl) methyl] benzamide, the preparation method thereof and application of same in therapeutics |
| 01/12/2010 | CA2461946C Combinations for the treatment of immunoinflammatory disorders |
| 01/12/2010 | CA2407463C N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 01/12/2010 | CA2391643C Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors |
| 01/12/2010 | CA2387675C Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 01/12/2010 | CA2384018C Muscarinic antagonists |
| 01/12/2010 | CA2324339C Piperidine derivatives |
| 01/12/2010 | CA2306428C 3-oxo-2(h)-1,2,4 - triazine derivatives as ligands of 5ht1a receptors |
| 01/12/2010 | CA2201781C Chronic rheumatoid arthritis therapy containing il-6 antagonist as effective component |
| 01/12/2010 | CA2192089C Inhibitors of interleukin-1.beta. converting enzyme |
| 01/07/2010 | WO2010001990A1 Tetracyclic compound |
| 01/07/2010 | WO2010001989A1 Agent for reducing cancer stem cell and/or cancer progenitor cell, and agent for preventing recurrence and/or metastasis of cancer |
| 01/07/2010 | WO2010001946A1 Triazole derivative or salt thereof |
| 01/07/2010 | WO2010001933A1 Histone modification inhibitor specific to target gene |
| 01/07/2010 | WO2010001909A1 Double-stranded polynucleotide |
| 01/07/2010 | WO2010001869A1 Tetra-substituted benzene compound and use thereof |
| 01/07/2010 | WO2010001821A1 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative and use of the pharmaceutical composition |
| 01/07/2010 | WO2010001509A1 Novel lactic acid bacterium having high immunoglobulin-a-inducing ability |
| 01/07/2010 | WO2010001102A2 Method |
| 01/07/2010 | WO2009140204A3 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 01/07/2010 | US20100004342 LFA-1 Inhibitors and Use Thereof |
| 01/07/2010 | US20100004327 Novel Use of Ansamycin Antibiotics And Method of Screening Novel Angiogenesis Inhibitor |
| 01/07/2010 | US20100004320 Pharmaceutical Composition |
| 01/07/2010 | US20100004285 POLYMORPH OF 4-[2-[4-[1-(2-ETHOXYETHYL)-1H-BENZIMIDAZOLE-2-YL]-1-PIPERIDINYL]ETHYL]-alpha alpha-DIMETHYL-BENZENEACETIC ACID |
| 01/07/2010 | US20100004281 Viral inhibitors |
| 01/07/2010 | US20100004241 Non-imidazole aryloxyalkylamines |
| 01/07/2010 | US20100004236 Phosphodiesterase 4 inhibitors |
| 01/07/2010 | US20100004194 Use of isomaltulose in food products having a regenerative effect |
| 01/07/2010 | US20100004170 Protein-containing substance with increased thermal stability |
| 01/07/2010 | US20100003336 Vesicles of self-assembling block copolymers and methods for making and using the same |
| 01/07/2010 | US20100003335 Microparticles for delivery to cells and/or tissue |
| 01/07/2010 | US20100003332 Process For Preparing Powder Comprising Nanoparticles of Sparingly Soluble Drug |
| 01/07/2010 | US20100003317 Compositions and methods for mediating rnai in vivo |
| 01/07/2010 | US20100003312 External skin patch |
| 01/07/2010 | US20100003308 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 01/07/2010 | US20100003307 Composition and use of rar antagonists for promoting chondrogenesis |
| 01/07/2010 | US20100003303 Polymers of fluorinated monomers and hydrocarbon monomers |
| 01/07/2010 | US20100003302 Vascular restenosis preventing agent and implantable intravascular device coated therewith |
| 01/07/2010 | US20100003297 Implantable Drug Delivery Device and Methods of Treating Male Genitourinary and Surrounding Tissues |
| 01/07/2010 | US20100003242 antibody that binds sphingosine-1-phosphate (S1P); used for detection of S1P or for treatment of diseases and conditions associated with S1P |
| 01/07/2010 | US20100003234 Cellulase activity; used to make bioethanol, in food and textile treatment, in waste treatment; breaks down lignocellulose |
| 01/07/2010 | US20100003223 Method for the production of multicomponent stem cells, relative kits and uses in the medical field |
| 01/07/2010 | CA2729408A1 Triazole derivative or salt thereof |
| 01/07/2010 | CA2729405A1 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition |
| 01/07/2010 | CA2729369A1 Method |
| 01/06/2010 | EP2141160A1 Ground crystal of olmesartan medoxomil |
| 01/06/2010 | EP2141155A1 Prophylactic and/or therapeutic agent for hyperlipemia |
| 01/06/2010 | EP2141154A1 Oxazolidinone derivative having inhibitory activity on 11 -hydroxysteroid dehydrogenase type i |
| 01/06/2010 | EP2141147A1 Ornithine derivative |
| 01/06/2010 | EP2141146A1 Calcilytic compounds |
| 01/06/2010 | EP2140879A1 Composition and method for treating cancer using herpes virus |
| 01/06/2010 | EP2140876A1 Therapeutic agent comprising vasohibin |
| 01/06/2010 | EP2140864A2 Use of GAL3 receptor antagonists for the treatment of depression and / or anxiety and compounds useful in such methods |
| 01/06/2010 | EP2140862A2 Use of GAL 3 receptor antagonists for the treatment of depression and /or anxiety and compounds useful in such methods |
| 01/06/2010 | EP2139474A2 Transcription factor modulating compounds and methods of use thereof |
| 01/06/2010 | EP2139325A2 Anti-angiogenic agents and methods of use |
| 01/06/2010 | EP1513831B1 Novel compounds, their use and preparation |